Skip to content

Vera Therapeutics VERA Change in Other Current Assets

Change in Other Current Assets at other companies

TG Therapeutics logo
TG TherapeuticsTGTX
-$10.66M-330%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's change in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's change in other current assets?
Vera Therapeutics (VERA) reported change in other current assets of $0 in Q1 2026.
How has Vera Therapeutics's change in other current assets changed year-over-year?
Vera Therapeutics's change in other current assets increased by 100.0% year-over-year, from -$17K to $0.
What is the long-term trend for Vera Therapeutics's change in other current assets?
Over 2 years (2021 to 2024), Vera Therapeutics's change in other current assets has grown at a 162.3% compound annual growth rate (CAGR), from $51K to -$351K.
What does change in other current assets mean?
Change in miscellaneous current assets not classified in specific working capital categories.